James Kinley - Net Worth and Insider Trading

James Kinley Net Worth

The estimated net worth of James Kinley is at least $24,279 dollars as of 2024-11-13. James Kinley is the Senior Officer of Algernon Pharmaceuticals Inc and owns about 303,492 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) stock worth over $24,279. Details can be seen in James Kinley's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Kinley has not made any transactions after 2024-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James Kinley

To

James Kinley Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Kinley owns 1 companies in total, including Algernon Pharmaceuticals Inc (XCNQ:AGN) .

Click here to see the complete history of James Kinley’s form 4 insider trades.

Insider Ownership Summary of James Kinley

Ticker Comapny Transaction Date Type of Owner
XCNQ:AGN Algernon Pharmaceuticals Inc 2024-05-16 Senior Officer

James Kinley Latest Holdings Summary

James Kinley currently owns a total of 1 stock. James Kinley owns 303,492 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) as of May 16, 2024, with a value of $24,279.

Latest Holdings of James Kinley

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XCNQ:AGN Algernon Pharmaceuticals Inc 2024-05-16 303,492 0.08 24,279

Holding Weightings of James Kinley


James Kinley Form 4 Trading Tracker

According to the SEC Form 4 filings, James Kinley has made a total of 5 transactions in Algernon Pharmaceuticals Inc (XCNQ:AGN) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Algernon Pharmaceuticals Inc is the acquisition of 12,500 shares on May 16, 2024, which cost James Kinley around $1,563.

Insider Trading History of James Kinley

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James Kinley Trading Performance

GuruFocus tracks the stock performance after each of James Kinley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Kinley is -35.98%. GuruFocus also compares James Kinley's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Kinley within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James Kinley's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James Kinley

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -13.9 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -8.6 LIMIT LIMIT LIMIT LIMIT LIMIT

James Kinley Ownership Network

Ownership Network List of James Kinley

No Data

Ownership Network Relation of James Kinley

Insider Network Chart

James Kinley Owned Company Details

What does Algernon Pharmaceuticals Inc do?

Who are the key executives at Algernon Pharmaceuticals Inc?

James Kinley is the Senior Officer of Algernon Pharmaceuticals Inc. Other key executives at Algernon Pharmaceuticals Inc include Director & Senior Officer Christopher Moreau , Senior Officer Christopher Scott Bryan , and Senior Officer Michael Sadhra .

Algernon Pharmaceuticals Inc (XCNQ:AGN) Insider Trades Summary

Over the past 18 months, James Kinley made 1 insider transaction in Algernon Pharmaceuticals Inc (XCNQ:AGN) with a net purchase of 12,500. Other recent insider transactions involving Algernon Pharmaceuticals Inc (XCNQ:AGN) include a net purchase of 62,500 shares made by Christopher Moreau , a net purchase of 60,500 shares made by Christopher Scott Bryan ,

In summary, during the past 3 months, insiders sold 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) were sold and 135,500 shares were bought by its insiders, resulting in a net purchase of 135,500 shares.

Algernon Pharmaceuticals Inc (XCNQ:AGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Algernon Pharmaceuticals Inc Insider Transactions

No Available Data

James Kinley Mailing Address

Above is the net worth, insider trading, and ownership report for James Kinley. Currently GuruFocus does not have mailing address information for James Kinley.